Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor

被引:47
|
作者
Cleary, Joanne
Johnson, Kathryn M.
Opipari, Anthony W.
Glick, Gary D.
机构
[1] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA
关键词
apoptosis; mitochondria; drug;
D O I
10.1016/j.bmcl.2006.12.102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although PK11195 binds to the peripheral benzodiazepine receptor with nanomolar affinity, significant data exist which suggest that it has another cellular target distinct from the PBR. Here we demonstrate that PK11195 inhibits F1F0-ATPase activity in an OSCP-dependent manner, similar to the pro-apoptotic benzodiazepine Bz-423. Importantly, our data indicate that cellular responses observed with micromolar concentrations of PK11195, which are commonly attributed to modulation of the PBR, are likely a direct result of mitochondrial F1F0-ATPase inhibition. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1667 / 1670
页数:4
相关论文
共 50 条
  • [1] Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase
    Pagliarani, Alessandra
    Nesci, Salvatore
    Ventrella, Vittoria
    MITOCHONDRION, 2013, 13 (04) : 312 - 319
  • [2] INHIBITION OF MITOCHONDRIAL F1F0-ATPASE BY PGBX, A DERIVATIVE OF PROSTAGLANDIN-B1
    KREUTTER, DK
    DEVLIN, TM
    FEDERATION PROCEEDINGS, 1980, 39 (06) : 2151 - 2151
  • [3] NMR Studies of an Immunomodulatory Benzodiazepine Binding to its Molecular Target on the Mitochondrial F1F0-ATPase
    Stelzer, Andrew C.
    Frazee, Richard W.
    Van Huis, Chad
    Cleary, Joanne
    Opipari, Anthony W., Jr.
    Glick, Gary D.
    Al-Hashimi, Hashim M.
    BIOPOLYMERS, 2010, 93 (01) : 85 - 92
  • [4] The IF1 inhibitor protein of the mitochondrial F1F0-ATPase
    Green, DW
    Grover, GJ
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2000, 1458 (2-3): : 343 - 355
  • [5] Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity
    Bosetti, F
    Yu, GY
    Zucchi, R
    Ronca-Testoni, S
    Solaini, G
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2000, 215 (1-2) : 31 - 37
  • [6] Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase
    Johnson, Kathryn M.
    Cleary, Joanne
    Fierke, Carol A.
    Opipari, Anthony W., Jr.
    Glick, Gary D.
    ACS CHEMICAL BIOLOGY, 2006, 1 (05) : 304 - 308
  • [7] Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423
    Johnson, KM
    Chen, XN
    Boitano, A
    Swenson, L
    Opipari, AW
    Glick, GD
    CHEMISTRY & BIOLOGY, 2005, 12 (04): : 485 - 496
  • [8] Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity
    Francesca Bosetti
    Gongyuan Yu
    Riccardo Zucchi
    Simonetta Ronca-Testoni
    Giancarlo Solaini
    Molecular and Cellular Biochemistry, 2000, 215 : 31 - 38
  • [9] Mechanistic Basis for Differential Inhibition of the F1F0-ATPase by Aurovertin
    Johnson, Kathryn M.
    Swenson, Lara
    Opiparl, Anthony W., Jr.
    Reuter, Rolf
    Zarrabi, Nawid
    Fierke, Carol A.
    Boersch, Michael
    Glick, Gary D.
    BIOPOLYMERS, 2009, 91 (10) : 830 - 840
  • [10] A switch in enantiomer preference between mitochondrial F1F0-ATPase chemotypes
    Bisaha, SN
    Malley, MF
    Pudzianowski, A
    Monshizadegan, H
    Wang, P
    Madsen, CS
    Gougoutas, JZ
    Stein, PD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (11) : 2749 - 2751